LSA
MRNA icon

Leonteq Securities AG’s Moderna MRNA Stock Holding History

Leonteq Securities AG’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$864K Hold
17,000
– – 0.03% 315
2025
Q4 		$501K Buy
+17,000
New +$462K 0.02% 460

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Leonteq Securities AG's MRNA Position: Q1 2026 in Review

Leonteq Securities AG reduced its Moderna (MRNA) stake by 9.9% in Q1 2026, selling an estimated $1.55M and leaving 302,375 shares worth $15.4M. The position accounts for 0.57% of the portfolio, ranked #33.

Leonteq Securities AG first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $43.1M in Q2 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Leonteq Securities AG held 302,375 shares of Moderna worth $15.4M as of Q1 2026.
  • Leonteq Securities AG sold 33,291 Moderna shares in Q1 2026, an estimated $1.55M.
  • Moderna made up 0.57% of Leonteq Securities AG's portfolio in Q1 2026, its #33 holding.
  • Leonteq Securities AG first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
  • Leonteq Securities AG's Moderna position peaked at $43.1M in Q2 2022.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.